DNA診断薬市場DNA Diagnostics Market DNA診断薬市場。世界の産業分析2015-2021年および機会評価2022-2032年 FMIが発行したDNA診断に関する最新市場調査は、2015-2021年の世界産業分析と2022-2032年の機会評価を提供しています。本調査では、最も重要... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリーDNA診断薬市場。世界の産業分析2015-2021年および機会評価2022-2032年FMIが発行したDNA診断に関する最新市場調査は、2015-2021年の世界産業分析と2022-2032年の機会評価を提供しています。本調査では、最も重要な市場力学の包括的な評価を提供しています。過去と現在の成長パラメータについて徹底的な調査を行った後、市場の成長見通しを最大限の精度で得ています。 市場の細分化 DNA診断の世界市場は、市場のあらゆる側面をカバーし、読者に完全な市場情報を提示するために詳細にセグメント化されています。 DNA Diagnosticsの製品タイプ別分類 - DNA Diagnostics Instruments - DNA Diagnostics Reagents - DNA Diagnosticsソフトウェア&サービス DNA Diagnostics 技術別 - PCR-based DNA Diagnostics - マイクロアレイベースの DNA 診断法 - In-situ Hybridization ベースの DNA 診断法 - シーケンサーによるDNA診断 - 質量分析ベースの DNA 診断法 アプリケーション別 DNA 診断法 - オンコロジーにおける DNA 診断法 o 前立腺癌 o 乳癌 o 大腸癌 o その他 - 感染症治療におけるDNA診断薬 o B型肝炎ウイルス o C型肝炎ウイルス o HIV o 結核 o クラミジア・トラコマティック・ナイセリア・淋病(CT/NG) o HPV メチシリン耐性黄色ブドウ球菌(MRSA) o その他 - 筋原性障害治療におけるDNA診断薬 - 臨床診断の確認におけるDNA診断法 - 出生前DNA診断 - 着床前DNA診断 - その他のアプリケーションにおけるDNA診断 エンドユーザー別DNA診断 - Point of Care DNA Diagnostics - 診断センターにおけるDNA診断 - 自己検査/OTC用DNA診断薬 DNA Diagnosticsの地域別市場 - 北米DNA Diagnostics市場 - 欧州DNA診断薬市場 - アジア太平洋地域のDNA診断薬市場 - 中東・アフリカDNA診断薬市場 - ラテンアメリカのDNA診断薬市場 レポートの章立て エグゼクティブサマリー DNA診断薬市場のエグゼクティブサマリーには、世界市場の展望、需要サイドの動向、供給サイドの動向、DNA診断薬に関するFMI分析および推奨事項が含まれています。 第01章 市場の概要 本章では、DNA 診断薬市場の詳細な区分と定義について説明し、DNA 診断薬に関する基本的な情報を理解するのに役立てます。また、市場の範囲、分類、制限をハイライトし、読者がDNA Diagnostics Market Reportの市場範囲を理解するのに役立ちます。 第02章 市場の背景 本章では、製品加工方法の概要、消費者の購買パターン&傾向、政策展開と規制シナリオの詳細な分析が含まれています。また、マクロ経済要因の詳細な分析も含まれており、世界のGDP成長見通し、世界の産業付加価値、個人消費、支出、現代貿易の普及、消費者物価指数などのトピックをカバーしています。本章では、市場をより深く理解するために、予測要因-関連性と影響、バリューチェーン分析、市場ダイナミクス(推進要因、抑制要因、機会)についても取り上げています。 第03章 DNA診断薬の世界市場需要分析2015-2021年および予測、2022-2032年 本章では、過去の市場価値(209億米ドル)分析(2015-2021年)、現在および将来の市場価値(515億米ドル)および数量(8.4%)予測(2022-2032年)を掲載します。予測は、前年比成長トレンド分析および絶対金額機会分析国に基づいています。 第04章 DNA診断薬の世界市場 - 価格設定分析 オファリング別に、価格分析章では、地域別価格分析(USD/MT)、世界平均価格分析ベンチマーク、価格に影響を与える主要因を含んでいます。 第05章 DNA診断薬の世界市場分析2015-2021年および予測2022-2032年、製品タイプ別 製品タイプ別に、DNA Diagnostics市場はDNA Diagnostics Instruments、DNA Diagnostics Reagents、DNA Diagnostics Software & Servicesに区分されます。また、製品タイプ別の市場魅力度分析も行っています。また、上記の製品タイプ別の価値予測および前年比成長率比較も提供します。 第06章 DNA診断薬の世界市場分析2015-2021年および予測2022-2032年:技術別 技術別に、DNA診断薬市場はPCRベースのDNA診断薬、マイクロアレイベースのDNA診断薬、In-situ HybridizationベースのDNA診断薬、シークエンス技術ベースのDNA診断薬、質量分析ベースのDNA診断薬に区分されます。また、「技術別」に基づく市場魅力度分析も行っています。また、上記の技術別に価値予測や前年比成長率の比較も行います。 第07章 DNA診断薬の世界市場分析2015-2021年および予測2022-2032年、用途別 DNA診断薬市場は、アプリケーション別に、腫瘍診断薬(前立腺癌、乳癌、大腸癌、その他)、感染症診断薬(B型肝炎ウイルス、C型肝炎ウイルス、HIV、結核、クラミジア・トラコチック・淋菌(CT/NG)、HPV、メチシリン耐性淋菌、その他)で区分されています。HPV、メチシリン耐性黄色ブドウ球菌(MRSA)、その他)、筋原性障害治療における DNA 診断、臨床診断確認における DNA 診断、出生前 DNA 診断、着床前 DNA 診断、その他の用途における DNA 診断。このセクションでは、アプリケーション別に市場の魅力度分析を行います。また、上記アプリケーション別の価値予測やYoY成長率比較も提供されます。 第08章 DNA診断薬の世界市場分析2015-2021年および予測2022-2032年(エンドユーザー別 エンドユーザー別では、Point of Care DNA Diagnostics、診断センターでのDNA Diagnostics、Self-Testing/OTC DNA Diagnosticsに分類されます。また、エンドユーザー別の市場魅力度分析も行っています。また、上記のエンドユーザー別の価値予測や前年比成長率比較も提供します。 第09章 DNA診断薬の世界市場分析2015-2021年および予測2022-2032年(地域別 DNA診断薬市場は地域別に、北米DNA診断薬市場、ヨーロッパDNA診断薬市場、アジア太平洋DNA診断薬市場、中東・アフリカDNA診断薬市場、中南米DNA診断薬市場に分類されます。このセクションでは、地域別の市場魅力度分析も提供しています。また、上記地域別の市場規模予測や前年比成長率比較もご覧いただけます。 第10章 北米DNA診断薬市場の分析2015-2021年および予測2022-2032年 本章では、北米地域におけるDNA診断薬の成長について、米国とカナダを含む国別の評価とともに詳細に分析します。また、北米地域の異なるセグメントや国に基づいた地域動向、規制、市場成長もご覧いただけます。 第11章 ラテンアメリカのDNA診断市場分析2015-2021年および予測2022-2032年 本章では、中南米地域におけるDNA診断薬の成長について、ブラジル、メキシコ、チリ、アルゼンチン、ペルー、その他の中南米を含む国別の評価とともに、詳細な分析を行います。中南米地域におけるDNA診断薬市場の成長に影響を及ぼしている価格分析や地域動向など、いくつかの要因についての詳細情報をご覧いただけます。 第12章 欧州DNA診断薬市場の分析2015-2021年および予測2022-2032年 本章では、ドイツ、イタリア、フランス、イギリス、スペイン、ロシア、北欧、ベネルクス、その他のヨーロッパを含む国別評価とともに、ヨーロッパ地域におけるDNA診断薬の成長についての詳細な分析を掲載します。読者は、地域市場におけるDNA Diagnostics市場の成長に影響を与える価格分析や地域動向などのいくつかの要因に関する詳細な情報を見つけることができます。 第13章 東アジアのDNA診断薬市場分析2015-2021年および予測2022-2032年 本章では、東アジア地域におけるDNA診断薬の成長について、中国、日本、韓国を含む国別の評価とともに詳細に分析します。読者は、地域市場におけるDNA診断薬市場の成長に影響を与える価格分析および地域動向などのいくつかの要因に関する詳細な情報を得ることができます。 第14章 南アジアのDNA診断薬市場分析2015-2021年および予測2022-2032年 本章では、南アジア地域におけるDNA診断薬の成長について、インド、インドネシア、マレーシア、タイ、その他の南アジア地域を含む国別の評価とともに、詳細な分析を行います。読者は、地域市場におけるDNA Diagnostics市場の成長に影響を与える価格分析および地域動向などのいくつかの要因に関する詳細情報を見つけることができます。 第15章 中東およびアフリカのDNA診断薬市場分析2015-2021年および予測2022-2032年 本章では、MEA地域におけるDNA診断薬の成長に関する詳細な分析を、GCC諸国、南アフリカ、北アフリカ、トルコ、その他のMEAを含む国別の評価とともに掲載します。読者は、地域市場におけるDNA Diagnostics市場の成長に影響を与える価格分析や地域動向などのいくつかの要因に関する詳細な情報を見つけることができます。 第16章 主要国DNA診断薬市場分析2015-2021年および予測2022-2032年 本章では、世界の主要国においてDNA診断薬市場がどのように成長すると予想されるかについての洞察を提供します。 第17章 - 市場構造分析 - グローバルな評価 本章では、企業ダッシュボード、企業の階層別産業構造分析、2022E、トッププレイヤーの企業シェア分析、2022E、競合ベンチマーキング-マトリクスを掲載しています。 第18章 競合のディープダイブ(暫定リスト) 本章では、Sysmex、Bayer Diagnostic、Roche Diagnostics、Abbott Laboratories、Cephide Incなどの企業概要を紹介します。 第19章 前提条件と頭字語 本章では、DNA Diagnostics レポートに含まれる情報や統計のベースとなる頭字語や仮定をリストアップしています。 第20章 - 調査方法論 本章では、DNA診断薬市場に関する様々な結論や重要な定性的・定量的情報を得るために実施した調査方法について読者に理解していただくためのものです。 目次1. Executive Summary1.1. Global Market Outlook 1.2. Summary of Statistics 1.3. Key Market Characteristics & Attributes 1.4. FMI Analysis and Recommendations 2. Market Overview 2.1. Market Coverage 2.2. Market Definition 3. Market Risks and Trends Assessment 3.1. Risk Assessment 3.1.1. COVID-19 Crisis and Impact on DNA Diagnostics 3.1.2. COVID-19 Impact Benchmark with Previous Crisis 3.1.3. Impact on Market Value (US$ Mn) 3.1.4. Assessment by Key Countries 3.1.5. Assessment by Key Market Segments 3.1.6. Action Points and Recommendation for Suppliers 3.2. Key Trends Impacting the Market 3.3. Formulation and Product Development Trends 4. Market Background 4.1. DNA Diagnostics Market, by Key Countries 4.2. DNA Diagnostics Market Opportunity Assessment (US$ Mn) 4.2.1. Total Available Market 4.2.2. Serviceable Addressable Market 4.2.3. Serviceable Obtainable Market 4.3. Market Scenario Forecast 4.3.1. Demand in optimistic Scenario 4.3.2. Demand in Likely Scenario 4.3.3. Demand in Conservative Scenario 4.4. Investment Feasibility Analysis 4.4.1. Investment in Established Markets 4.4.1.1. In Short Term 4.4.1.2. In Long Term 4.4.2. Investment in Emerging Markets 4.4.2.1. In Short Term 4.4.2.2. In Long Term 4.5. Forecast Factors - Relevance & Impact 4.5.1. Top Companies Historical Growth 4.5.2. Growth in Automation, By Country 4.5.3. DNA Diagnostics Adoption Rate, By Country 4.6. Market Dynamics 4.6.1. Market Driving Factors and Impact Assessment 4.6.2. Prominent Market Challenges and Impact Assessment 4.6.3. DNA Diagnostics Market Opportunities 4.6.4. Prominent Trends in the Global Market & Their Impact Assessment 5. Key Success Factors 5.1. Manufacturers’ Focus on Low Penetration High Growth Markets 5.2. Banking on with Segments High Incremental Opportunity 5.3. Peer Benchmarking 6. Global DNA Diagnostics Market Demand Analysis 2015-2021 and Forecast, 2022-2032 6.1. Historical Market Analysis, 2015-2021 6.2. Current and Future Market Projections, 2022-2032 6.3. Y-o-Y Growth Trend Analysis 7. Global DNA Diagnostics Market Value Analysis 2015-2021 and Forecast, 2022-2032 7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021 7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Global DNA Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By Product Type 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Mn) Analysis By Product Type , 2015-2021 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type , 2022-2032 8.3.1. Instruments 8.3.2. Reagents 8.3.3. Service & Software 8.4. Market Attractiveness Analysis By Product Type 9. Global DNA Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By Technology 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Mn) Analysis By Technology , 2015-2021 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technology , 2022-2032 9.3.1. PCR 9.3.2. Microarray 9.3.3. In-situ Hybridization 9.3.4. Sequencing Technology 9.3.5. Mass Spectrometry 9.3.6. Others 9.4. Market Attractiveness Analysis By Technology 10. Global DNA Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By Application 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) Analysis By Application , 2015-2021 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application , 2022-2032 10.3.1. Oncology 10.3.1.1. Prostate Cancer 10.3.1.2. Breast Cancer 10.3.1.3. Colorectal Cancer 10.3.1.4. Others 10.3.2. Infectious Disease 10.3.2.1. Hepatitis B Virus 10.3.2.2. Hepatitis C Virus 10.3.2.3. HIV 10.3.2.4. TB 10.3.2.5. Chlamydia Trachomatic and Neisseria Gonorrhea (CT/NG) 10.3.2.6. HPV 10.3.2.7. Methiciline Resistant Staphylococcus Aureus (MRSA) 10.3.2.8. Others 10.3.3. Myogenic Disorder 10.3.4. Clinical Diagnostic Confirmation 10.3.5. Prenatal Diagnostics 10.3.6. Pre-implantation Diagnostics 10.3.7. Others 10.4. Market Attractiveness Analysis By Application 11. Global DNA Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By End User 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Analysis By End User , 2015-2021 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User , 2022-2032 11.3.1. Point of Care 11.3.2. Diagnostic Center 11.3.3. Self Testing/OTC 11.4. Market Attractiveness Analysis By End User 12. Global DNA Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By Region 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021 12.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032 12.3.1. North America 12.3.2. Latin America 12.3.3. Europe 12.3.4. Asia Pacific 12.3.5. Middle East and Africa (MEA) 12.4. Market Attractiveness Analysis By Region 13. North America DNA Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032 13.1. Introduction 13.2. Pricing Analysis 13.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 13.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 13.4.1. By Country 13.4.1.1. U.S. 13.4.1.2. Canada 13.4.1.3. Rest of North America 13.4.2. By Product Type 13.4.3. By Technology 13.4.4. By End User 13.4.5. By Application 13.5. Market Attractiveness Analysis 13.5.1. By Country 13.5.2. By Product Type 13.5.3. By Technology 13.5.4. By End User 13.5.5. By Application 14. Latin America DNA Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032 14.1. Introduction 14.2. Pricing Analysis 14.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 14.4.1. By Country 14.4.1.1. Brazil 14.4.1.2. Mexico 14.4.1.3. Rest of Latin America 14.4.2. By Product Type 14.4.3. By Technology 14.4.4. By End User 14.4.5. By Application 14.5. Market Attractiveness Analysis 14.5.1. By Country 14.5.2. By Product Type 14.5.3. By Technology 14.5.4. By End User 14.5.5. By Application 15. Europe DNA Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032 15.1. Introduction 15.2. Pricing Analysis 15.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 15.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 15.4.1. By Country 15.4.1.1. Germany 15.4.1.2. France 15.4.1.3. U.K. 15.4.1.4. Italy 15.4.1.5. Benelux 15.4.1.6. Nordic Countries 15.4.1.7. Rest of Europe 15.4.2. By Product Type 15.4.3. By Technology 15.4.4. By End User 15.4.5. By Application 15.5. Market Attractiveness Analysis 15.5.1. By Country 15.5.2. By Product Type 15.5.3. By Technology 15.5.4. By End User 15.5.5. By Application 16. Asia Pacific DNA Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032 16.1. Introduction 16.2. Pricing Analysis 16.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 16.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 16.4.1. By Country 16.4.1.1. China 16.4.1.2. Japan 16.4.1.3. South Korea 16.4.1.4. Rest of Asia Pacific 16.4.2. By Product Type 16.4.3. By Technology 16.4.4. By End User 16.4.5. By Application 16.5. Market Attractiveness Analysis 16.5.1. By Country 16.5.2. By Product Type 16.5.3. By Technology 16.5.4. By End User 16.5.5. By Application 17. Middle East and Africa DNA Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032 17.1. Introduction 17.2. Pricing Analysis 17.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 17.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 17.4.1. By Country 17.4.1.1. GCC Countries 17.4.1.2. South Africa 17.4.1.3. Turkey 17.4.1.4. Rest of Middle East and Africa 17.4.2. By Product Type 17.4.3. By Technology 17.4.4. By End User 17.4.5. By Application 17.5. Market Attractiveness Analysis 17.5.1. By Country 17.5.2. By Product Type 17.5.3. By Technology 17.5.4. By End User 17.5.5. By Application 18. Key Countries DNA Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032 18.1. Introduction 18.1.1. Market Value Proportion Analysis, By Key Countries 18.1.2. Global Vs. Country Growth Comparison 18.2. US DNA Diagnostics Market Analysis 18.2.1. Value Proportion Analysis by Market Taxonomy 18.2.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032 18.2.2.1. By Product Type 18.2.2.2. By Technology 18.2.2.3. By End User 18.2.2.4. By Application 18.3. Canada DNA Diagnostics Market Analysis 18.3.1. Value Proportion Analysis by Market Taxonomy 18.3.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032 18.3.2.1. By Product Type 18.3.2.2. By Technology 18.3.2.3. By End User 18.3.2.4. By Application 18.4. Mexico DNA Diagnostics Market Analysis 18.4.1. Value Proportion Analysis by Market Taxonomy 18.4.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032 18.4.2.1. By Product Type 18.4.2.2. By Technology 18.4.2.3. By End User 18.4.2.4. By Application 18.5. Brazil DNA Diagnostics Market Analysis 18.5.1. Value Proportion Analysis by Market Taxonomy 18.5.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032 18.5.2.1. By Product Type 18.5.2.2. By Technology 18.5.2.3. By End User 18.5.2.4. By Application 18.6. Germany DNA Diagnostics Market Analysis 18.6.1. Value Proportion Analysis by Market Taxonomy 18.6.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032 18.6.2.1. By Product Type 18.6.2.2. By Technology 18.6.2.3. By End User 18.6.2.4. By Application 18.7. France DNA Diagnostics Market Analysis 18.7.1. Value Proportion Analysis by Market Taxonomy 18.7.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032 18.7.2.1. By Product Type 18.7.2.2. By Technology 18.7.2.3. By End User 18.7.2.4. By Application 18.8. Italy DNA Diagnostics Market Analysis 18.8.1. Value Proportion Analysis by Market Taxonomy 18.8.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032 18.8.2.1. By Product Type 18.8.2.2. By Technology 18.8.2.3. By End User 18.8.2.4. By Application 18.9. BENELUX DNA Diagnostics Market Analysis 18.9.1. Value Proportion Analysis by Market Taxonomy 18.9.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032 18.9.2.1. By Product Type 18.9.2.2. By Technology 18.9.2.3. By End User 18.9.2.4. By Application 18.10. UK DNA Diagnostics Market Analysis 18.10.1. Value Proportion Analysis by Market Taxonomy 18.10.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032 18.10.2.1. By Product Type 18.10.2.2. By Technology 18.10.2.3. By End User 18.10.2.4. By Application 18.11. Nordic Countries DNA Diagnostics Market Analysis 18.11.1. Value Proportion Analysis by Market Taxonomy 18.11.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032 18.11.2.1. By Product Type 18.11.2.2. By Technology 18.11.2.3. By End User 18.11.2.4. By Application 18.12. China DNA Diagnostics Market Analysis 18.12.1. Value Proportion Analysis by Market Taxonomy 18.12.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032 18.12.2.1. By Product Type 18.12.2.2. By Technology 18.12.2.3. By End User 18.12.2.4. By Application 18.13. Japan DNA Diagnostics Market Analysis 18.13.1. Value Proportion Analysis by Market Taxonomy 18.13.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032 18.13.2.1. By Product Type 18.13.2.2. By Technology 18.13.2.3. By End User 18.13.2.4. By Application 18.14. South Korea DNA Diagnostics Market Analysis 18.14.1. Value Proportion Analysis by Market Taxonomy 18.14.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032 18.14.2.1. By Product Type 18.14.2.2. By Technology 18.14.2.3. By End User 18.14.2.4. By Application 18.15. GCC Countries DNA Diagnostics Market Analysis 18.15.1. Value Proportion Analysis by Market Taxonomy 18.15.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032 18.15.2.1. By Product Type 18.15.2.2. By Technology 18.15.2.3. By End User 18.15.2.4. By Application 18.16. South Africa DNA Diagnostics Market Analysis 18.16.1. Value Proportion Analysis by Market Taxonomy 18.16.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032 18.16.2.1. By Product Type 18.16.2.2. By Technology 18.16.2.3. By End User 18.16.2.4. By Application 18.17. Turkey DNA Diagnostics Market Analysis 18.17.1. Value Proportion Analysis by Market Taxonomy 18.17.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032 18.17.2.1. By Product Type 18.17.2.2. By Technology 18.17.2.3. By End User 18.17.2.4. By Application 18.17.3. Competition Landscape and Player Concentration in the Country 19. Market Structure Analysis 19.1. Market Analysis by Tier of Companies 19.2. Market Concentration 19.3. Market Share Analysis of Top Players 19.4. Market Presence Analysis 19.4.1. By Regional footprint of Players 19.4.2. Product footprint by Players 20. Competition Analysis 20.1. Competition Dashboard 20.2. Competition Benchmarking 20.3. Competition Deep Dive 20.3.1. Sysmex 20.3.1.1. Overview 20.3.1.2. Product Portfolio 20.3.1.3. Sales Footprint 20.3.1.4. Strategy Overview 20.3.2. Bayer Diagnostic 20.3.2.1. Overview 20.3.2.2. Product Portfolio 20.3.2.3. Sales Footprint 20.3.2.4. Strategy Overview 20.3.3. Roche Diagnostics 20.3.3.1. Overview 20.3.3.2. Product Portfolio 20.3.3.3. Sales Footprint 20.3.3.4. Strategy Overview 20.3.4. Abbott Laboratories 20.3.4.1. Overview 20.3.4.2. Product Portfolio 20.3.4.3. Sales Footprint 20.3.4.4. Strategy Overview 20.3.5. Cephide Inc 20.3.5.1. Overview 20.3.5.2. Product Portfolio 20.3.5.3. Sales Footprint 20.3.5.4. Strategy Overview 20.3.6. Gen-probe Inc 20.3.6.1. Overview 20.3.6.2. Product Portfolio 20.3.6.3. Sales Footprint 20.3.6.4. Strategy Overview 20.3.7. Illumina, Inc 20.3.7.1. Overview 20.3.7.2. Product Portfolio 20.3.7.3. Sales Footprint 20.3.7.4. Strategy Overview 20.3.8. Thermo Fisher Scientific 20.3.8.1. Overview 20.3.8.2. Product Portfolio 20.3.8.3. Sales Footprint 20.3.8.4. Strategy Overview 20.3.9. Bio-Rad Laboratories 20.3.9.1. Overview 20.3.9.2. Product Portfolio 20.3.9.3. Sales Footprint 20.3.9.4. Strategy Overview 20.3.10. Johnson and Johnson 20.3.10.1. Overview 20.3.10.2. Product Portfolio 20.3.10.3. Sales Footprint 20.3.10.4. Strategy Overview 21. Assumptions and Acronyms Used 22. Research Methodology
SummaryDNA Diagnostics Market: Global Industry Analysis 2015-2021 and Opportunity Assessment 2022-2032 Table of Contents1. Executive Summary1.1. Global Market Outlook 1.2. Summary of Statistics 1.3. Key Market Characteristics & Attributes 1.4. FMI Analysis and Recommendations 2. Market Overview 2.1. Market Coverage 2.2. Market Definition 3. Market Risks and Trends Assessment 3.1. Risk Assessment 3.1.1. COVID-19 Crisis and Impact on DNA Diagnostics 3.1.2. COVID-19 Impact Benchmark with Previous Crisis 3.1.3. Impact on Market Value (US$ Mn) 3.1.4. Assessment by Key Countries 3.1.5. Assessment by Key Market Segments 3.1.6. Action Points and Recommendation for Suppliers 3.2. Key Trends Impacting the Market 3.3. Formulation and Product Development Trends 4. Market Background 4.1. DNA Diagnostics Market, by Key Countries 4.2. DNA Diagnostics Market Opportunity Assessment (US$ Mn) 4.2.1. Total Available Market 4.2.2. Serviceable Addressable Market 4.2.3. Serviceable Obtainable Market 4.3. Market Scenario Forecast 4.3.1. Demand in optimistic Scenario 4.3.2. Demand in Likely Scenario 4.3.3. Demand in Conservative Scenario 4.4. Investment Feasibility Analysis 4.4.1. Investment in Established Markets 4.4.1.1. In Short Term 4.4.1.2. In Long Term 4.4.2. Investment in Emerging Markets 4.4.2.1. In Short Term 4.4.2.2. In Long Term 4.5. Forecast Factors - Relevance & Impact 4.5.1. Top Companies Historical Growth 4.5.2. Growth in Automation, By Country 4.5.3. DNA Diagnostics Adoption Rate, By Country 4.6. Market Dynamics 4.6.1. Market Driving Factors and Impact Assessment 4.6.2. Prominent Market Challenges and Impact Assessment 4.6.3. DNA Diagnostics Market Opportunities 4.6.4. Prominent Trends in the Global Market & Their Impact Assessment 5. Key Success Factors 5.1. Manufacturers’ Focus on Low Penetration High Growth Markets 5.2. Banking on with Segments High Incremental Opportunity 5.3. Peer Benchmarking 6. Global DNA Diagnostics Market Demand Analysis 2015-2021 and Forecast, 2022-2032 6.1. Historical Market Analysis, 2015-2021 6.2. Current and Future Market Projections, 2022-2032 6.3. Y-o-Y Growth Trend Analysis 7. Global DNA Diagnostics Market Value Analysis 2015-2021 and Forecast, 2022-2032 7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021 7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Global DNA Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By Product Type 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Mn) Analysis By Product Type , 2015-2021 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type , 2022-2032 8.3.1. Instruments 8.3.2. Reagents 8.3.3. Service & Software 8.4. Market Attractiveness Analysis By Product Type 9. Global DNA Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By Technology 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Mn) Analysis By Technology , 2015-2021 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technology , 2022-2032 9.3.1. PCR 9.3.2. Microarray 9.3.3. In-situ Hybridization 9.3.4. Sequencing Technology 9.3.5. Mass Spectrometry 9.3.6. Others 9.4. Market Attractiveness Analysis By Technology 10. Global DNA Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By Application 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) Analysis By Application , 2015-2021 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application , 2022-2032 10.3.1. Oncology 10.3.1.1. Prostate Cancer 10.3.1.2. Breast Cancer 10.3.1.3. Colorectal Cancer 10.3.1.4. Others 10.3.2. Infectious Disease 10.3.2.1. Hepatitis B Virus 10.3.2.2. Hepatitis C Virus 10.3.2.3. HIV 10.3.2.4. TB 10.3.2.5. Chlamydia Trachomatic and Neisseria Gonorrhea (CT/NG) 10.3.2.6. HPV 10.3.2.7. Methiciline Resistant Staphylococcus Aureus (MRSA) 10.3.2.8. Others 10.3.3. Myogenic Disorder 10.3.4. Clinical Diagnostic Confirmation 10.3.5. Prenatal Diagnostics 10.3.6. Pre-implantation Diagnostics 10.3.7. Others 10.4. Market Attractiveness Analysis By Application 11. Global DNA Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By End User 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Analysis By End User , 2015-2021 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User , 2022-2032 11.3.1. Point of Care 11.3.2. Diagnostic Center 11.3.3. Self Testing/OTC 11.4. Market Attractiveness Analysis By End User 12. Global DNA Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By Region 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021 12.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032 12.3.1. North America 12.3.2. Latin America 12.3.3. Europe 12.3.4. Asia Pacific 12.3.5. Middle East and Africa (MEA) 12.4. Market Attractiveness Analysis By Region 13. North America DNA Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032 13.1. Introduction 13.2. Pricing Analysis 13.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 13.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 13.4.1. By Country 13.4.1.1. U.S. 13.4.1.2. Canada 13.4.1.3. Rest of North America 13.4.2. By Product Type 13.4.3. By Technology 13.4.4. By End User 13.4.5. By Application 13.5. Market Attractiveness Analysis 13.5.1. By Country 13.5.2. By Product Type 13.5.3. By Technology 13.5.4. By End User 13.5.5. By Application 14. Latin America DNA Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032 14.1. Introduction 14.2. Pricing Analysis 14.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 14.4.1. By Country 14.4.1.1. Brazil 14.4.1.2. Mexico 14.4.1.3. Rest of Latin America 14.4.2. By Product Type 14.4.3. By Technology 14.4.4. By End User 14.4.5. By Application 14.5. Market Attractiveness Analysis 14.5.1. By Country 14.5.2. By Product Type 14.5.3. By Technology 14.5.4. By End User 14.5.5. By Application 15. Europe DNA Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032 15.1. Introduction 15.2. Pricing Analysis 15.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 15.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 15.4.1. By Country 15.4.1.1. Germany 15.4.1.2. France 15.4.1.3. U.K. 15.4.1.4. Italy 15.4.1.5. Benelux 15.4.1.6. Nordic Countries 15.4.1.7. Rest of Europe 15.4.2. By Product Type 15.4.3. By Technology 15.4.4. By End User 15.4.5. By Application 15.5. Market Attractiveness Analysis 15.5.1. By Country 15.5.2. By Product Type 15.5.3. By Technology 15.5.4. By End User 15.5.5. By Application 16. Asia Pacific DNA Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032 16.1. Introduction 16.2. Pricing Analysis 16.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 16.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 16.4.1. By Country 16.4.1.1. China 16.4.1.2. Japan 16.4.1.3. South Korea 16.4.1.4. Rest of Asia Pacific 16.4.2. By Product Type 16.4.3. By Technology 16.4.4. By End User 16.4.5. By Application 16.5. Market Attractiveness Analysis 16.5.1. By Country 16.5.2. By Product Type 16.5.3. By Technology 16.5.4. By End User 16.5.5. By Application 17. Middle East and Africa DNA Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032 17.1. Introduction 17.2. Pricing Analysis 17.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 17.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 17.4.1. By Country 17.4.1.1. GCC Countries 17.4.1.2. South Africa 17.4.1.3. Turkey 17.4.1.4. Rest of Middle East and Africa 17.4.2. By Product Type 17.4.3. By Technology 17.4.4. By End User 17.4.5. By Application 17.5. Market Attractiveness Analysis 17.5.1. By Country 17.5.2. By Product Type 17.5.3. By Technology 17.5.4. By End User 17.5.5. By Application 18. Key Countries DNA Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032 18.1. Introduction 18.1.1. Market Value Proportion Analysis, By Key Countries 18.1.2. Global Vs. Country Growth Comparison 18.2. US DNA Diagnostics Market Analysis 18.2.1. Value Proportion Analysis by Market Taxonomy 18.2.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032 18.2.2.1. By Product Type 18.2.2.2. By Technology 18.2.2.3. By End User 18.2.2.4. By Application 18.3. Canada DNA Diagnostics Market Analysis 18.3.1. Value Proportion Analysis by Market Taxonomy 18.3.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032 18.3.2.1. By Product Type 18.3.2.2. By Technology 18.3.2.3. By End User 18.3.2.4. By Application 18.4. Mexico DNA Diagnostics Market Analysis 18.4.1. Value Proportion Analysis by Market Taxonomy 18.4.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032 18.4.2.1. By Product Type 18.4.2.2. By Technology 18.4.2.3. By End User 18.4.2.4. By Application 18.5. Brazil DNA Diagnostics Market Analysis 18.5.1. Value Proportion Analysis by Market Taxonomy 18.5.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032 18.5.2.1. By Product Type 18.5.2.2. By Technology 18.5.2.3. By End User 18.5.2.4. By Application 18.6. Germany DNA Diagnostics Market Analysis 18.6.1. Value Proportion Analysis by Market Taxonomy 18.6.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032 18.6.2.1. By Product Type 18.6.2.2. By Technology 18.6.2.3. By End User 18.6.2.4. By Application 18.7. France DNA Diagnostics Market Analysis 18.7.1. Value Proportion Analysis by Market Taxonomy 18.7.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032 18.7.2.1. By Product Type 18.7.2.2. By Technology 18.7.2.3. By End User 18.7.2.4. By Application 18.8. Italy DNA Diagnostics Market Analysis 18.8.1. Value Proportion Analysis by Market Taxonomy 18.8.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032 18.8.2.1. By Product Type 18.8.2.2. By Technology 18.8.2.3. By End User 18.8.2.4. By Application 18.9. BENELUX DNA Diagnostics Market Analysis 18.9.1. Value Proportion Analysis by Market Taxonomy 18.9.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032 18.9.2.1. By Product Type 18.9.2.2. By Technology 18.9.2.3. By End User 18.9.2.4. By Application 18.10. UK DNA Diagnostics Market Analysis 18.10.1. Value Proportion Analysis by Market Taxonomy 18.10.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032 18.10.2.1. By Product Type 18.10.2.2. By Technology 18.10.2.3. By End User 18.10.2.4. By Application 18.11. Nordic Countries DNA Diagnostics Market Analysis 18.11.1. Value Proportion Analysis by Market Taxonomy 18.11.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032 18.11.2.1. By Product Type 18.11.2.2. By Technology 18.11.2.3. By End User 18.11.2.4. By Application 18.12. China DNA Diagnostics Market Analysis 18.12.1. Value Proportion Analysis by Market Taxonomy 18.12.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032 18.12.2.1. By Product Type 18.12.2.2. By Technology 18.12.2.3. By End User 18.12.2.4. By Application 18.13. Japan DNA Diagnostics Market Analysis 18.13.1. Value Proportion Analysis by Market Taxonomy 18.13.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032 18.13.2.1. By Product Type 18.13.2.2. By Technology 18.13.2.3. By End User 18.13.2.4. By Application 18.14. South Korea DNA Diagnostics Market Analysis 18.14.1. Value Proportion Analysis by Market Taxonomy 18.14.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032 18.14.2.1. By Product Type 18.14.2.2. By Technology 18.14.2.3. By End User 18.14.2.4. By Application 18.15. GCC Countries DNA Diagnostics Market Analysis 18.15.1. Value Proportion Analysis by Market Taxonomy 18.15.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032 18.15.2.1. By Product Type 18.15.2.2. By Technology 18.15.2.3. By End User 18.15.2.4. By Application 18.16. South Africa DNA Diagnostics Market Analysis 18.16.1. Value Proportion Analysis by Market Taxonomy 18.16.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032 18.16.2.1. By Product Type 18.16.2.2. By Technology 18.16.2.3. By End User 18.16.2.4. By Application 18.17. Turkey DNA Diagnostics Market Analysis 18.17.1. Value Proportion Analysis by Market Taxonomy 18.17.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032 18.17.2.1. By Product Type 18.17.2.2. By Technology 18.17.2.3. By End User 18.17.2.4. By Application 18.17.3. Competition Landscape and Player Concentration in the Country 19. Market Structure Analysis 19.1. Market Analysis by Tier of Companies 19.2. Market Concentration 19.3. Market Share Analysis of Top Players 19.4. Market Presence Analysis 19.4.1. By Regional footprint of Players 19.4.2. Product footprint by Players 20. Competition Analysis 20.1. Competition Dashboard 20.2. Competition Benchmarking 20.3. Competition Deep Dive 20.3.1. Sysmex 20.3.1.1. Overview 20.3.1.2. Product Portfolio 20.3.1.3. Sales Footprint 20.3.1.4. Strategy Overview 20.3.2. Bayer Diagnostic 20.3.2.1. Overview 20.3.2.2. Product Portfolio 20.3.2.3. Sales Footprint 20.3.2.4. Strategy Overview 20.3.3. Roche Diagnostics 20.3.3.1. Overview 20.3.3.2. Product Portfolio 20.3.3.3. Sales Footprint 20.3.3.4. Strategy Overview 20.3.4. Abbott Laboratories 20.3.4.1. Overview 20.3.4.2. Product Portfolio 20.3.4.3. Sales Footprint 20.3.4.4. Strategy Overview 20.3.5. Cephide Inc 20.3.5.1. Overview 20.3.5.2. Product Portfolio 20.3.5.3. Sales Footprint 20.3.5.4. Strategy Overview 20.3.6. Gen-probe Inc 20.3.6.1. Overview 20.3.6.2. Product Portfolio 20.3.6.3. Sales Footprint 20.3.6.4. Strategy Overview 20.3.7. Illumina, Inc 20.3.7.1. Overview 20.3.7.2. Product Portfolio 20.3.7.3. Sales Footprint 20.3.7.4. Strategy Overview 20.3.8. Thermo Fisher Scientific 20.3.8.1. Overview 20.3.8.2. Product Portfolio 20.3.8.3. Sales Footprint 20.3.8.4. Strategy Overview 20.3.9. Bio-Rad Laboratories 20.3.9.1. Overview 20.3.9.2. Product Portfolio 20.3.9.3. Sales Footprint 20.3.9.4. Strategy Overview 20.3.10. Johnson and Johnson 20.3.10.1. Overview 20.3.10.2. Product Portfolio 20.3.10.3. Sales Footprint 20.3.10.4. Strategy Overview 21. Assumptions and Acronyms Used 22. Research Methodology
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(診断薬)の最新刊レポート
Future Market Insights社の診断薬分野での最新刊レポート本レポートと同じKEY WORD(diagnostics)の最新刊レポート
よくあるご質問Future Market Insights社はどのような調査会社ですか?Future Market Insights(FMI)は世界の広範な地域および産業を対象にした調査レポートを出版しています。 弊社ウェブサイトに掲載のないタイトルも全てお取り扱い可能ですので... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/14 10:27 156.77 円 166.04 円 201.95 円 |